← Open Payments lookup

JILL MCCARTNEY: Open Payments

NPI 1598364028 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,105 in 55 payments from 10 companies in 2025. Trend: 2023 $709 · 2024 $1,227 · 2025 $1,105

Food & beverage: $1,105
CompanyPaymentsAmount
Axsome Therapeutics, Inc.13$307
Neurocrine BioSciences, Inc.12$185
Alkermes, Inc.8$171
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$159
Teva Pharmaceuticals USA, Inc.5$99
Janssen Pharmaceuticals, Inc4$85
Supernus Pharmaceuticals, Inc.3$48
Otsuka America Pharmaceutical, Inc.1$20
E.R. Squibb & Sons, L.L.C.1$17
Almatica Pharma LLC1$14

Products named: Auvelity, INGREZZA, ARISTADA, CAPLYTA, SPRAVATO, AUSTEDO XR, Qelbree, UZEDY.

Industry payments across PA — which companies pay providers there.